Johnson & Johnson vaccine much less efficient towards Delta variant: research

A latest research from researchers at NYU’s Grossman Faculty of Medicines discovered that the Johnson & Johnson vaccine could also be much less efficient in battling COVID-19 variants than vaccines made by Pfizer-BioNTech or Moderna.

Leave a Reply

Your email address will not be published. Required fields are marked *